Lambda Therapeutic Research underlines its position as a leading global CRO with two prestigious awards. The company won the ‘Regulatory Excellence’ Award at the CPHI Awards 2023 and the ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023.

 

Lambda’s success continued with the prestigious ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023 in Barcelona on October 25, 2023. This award acknowledges Lambda’s innovative testing methods for biosimilars, novel approaches, and commitment to exceeding regulatory expectations set by esteemed global agencies such as the US FDA and EMA.
Mrs. Bindi Chudgar, Founder & Managing Director, upon receiving these prestigious awards, stated, “These remarkable achievements are a testament to the outstanding work of our exceptional team members, who have made these milestones possible by upholding the highest standards of regulatory compliance and innovation.”